chr15-48878241-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_014335.3(EID1):ā€‹c.65T>Cā€‹(p.Met22Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000096 in 1,458,072 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000096 ( 0 hom. )

Consequence

EID1
NM_014335.3 missense

Scores

1
5
13

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.99
Variant links:
Genes affected
EID1 (HGNC:1191): (EP300 interacting inhibitor of differentiation 1) Enables histone acetyltransferase binding activity and histone acetyltransferase regulator activity. Involved in cell differentiation and negative regulation of transcription, DNA-templated. Acts upstream of or within negative regulation of transcription by RNA polymerase II. Located in cytoplasmic ribonucleoprotein granule and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
SHC4 (HGNC:16743): (SHC adaptor protein 4) Predicted to enable receptor tyrosine kinase binding activity. Predicted to be involved in transmembrane receptor protein tyrosine kinase signaling pathway. Predicted to act upstream of or within several processes, including apoptotic process; positive regulation of cell population proliferation; and stem cell differentiation. Predicted to be located in postsynaptic membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.099462986).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
EID1NM_014335.3 linkuse as main transcriptc.65T>C p.Met22Thr missense_variant 1/1 ENST00000530028.3
SHC4NM_203349.4 linkuse as main transcriptc.840+6007A>G intron_variant ENST00000332408.9
SHC4XM_005254375.4 linkuse as main transcriptc.291+6007A>G intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
EID1ENST00000530028.3 linkuse as main transcriptc.65T>C p.Met22Thr missense_variant 1/1 NM_014335.3 P1Q9Y6B2-1
SHC4ENST00000332408.9 linkuse as main transcriptc.840+6007A>G intron_variant 1 NM_203349.4 P1Q6S5L8-1
EID1ENST00000560490.1 linkuse as main transcriptc.65T>C p.Met22Thr missense_variant 1/23

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.0000284
AC:
7
AN:
246268
Hom.:
0
AF XY:
0.0000150
AC XY:
2
AN XY:
133508
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000204
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000960
AC:
14
AN:
1458072
Hom.:
0
Cov.:
31
AF XY:
0.00000414
AC XY:
3
AN XY:
725036
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000180
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000270
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
Cov.:
32
Bravo
AF:
0.0000113
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 16, 2022The c.65T>C (p.M22T) alteration is located in exon 1 (coding exon 1) of the EID1 gene. This alteration results from a T to C substitution at nucleotide position 65, causing the methionine (M) at amino acid position 22 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.36
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.031
T;T
Eigen
Benign
-0.14
Eigen_PC
Benign
-0.026
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.40
T;T
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.099
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.5
L;.
MutationTaster
Benign
1.0
N;N;N;N;D
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.44
N;N
REVEL
Benign
0.076
Sift
Uncertain
0.0040
D;D
Sift4G
Uncertain
0.023
D;T
Polyphen
0.28
B;.
Vest4
0.31
MutPred
0.18
Gain of phosphorylation at M22 (P = 0.0336);Gain of phosphorylation at M22 (P = 0.0336);
MVP
0.10
MPC
0.31
ClinPred
0.34
T
GERP RS
4.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.70
gMVP
0.091

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs760215753; hg19: chr15-49170438; API